HDAC inhibitor confers radiosensitivity to prostate stem-like cells

F. M. Frame, D. Pellacani, A. T. Collins, M. S. Simms, V. M. Mann, Gdd Jones, M. Meuth, R. G. Bristow, N. J. Maitland*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'HDAC inhibitor confers radiosensitivity to prostate stem-like cells'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science